• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Dolly Sharma, PhD

Latest:

Cost of Home vs Clinic Administration of Paclitaxel in Metastatic Breast Cancer

Home administration of oral paclitaxel and encequidar is associated with potential cost savings for payers compared with clinic administration of intravenous chemotherapy in metastatic breast cancer patients.


Amiee Kang, MPH

Latest:

Journey to Anticoagulant Access Following Payer Rejection of Apixaban

Formulary restrictions can create treatment barriers for patients with atrial fibrillation, including unnecessary delays in treatment and prescription abandonment, with vulnerable populations at greater risk.


Jai Seth, MSc

Latest:

Leveraging Patient Activation to Improve Kidney Health in High-Risk Patients

Frequency of patient-provider conversations and patient activation are the 2 most significant predictors of a high-risk patient’s behaviors to prevent kidney disease.

© 2025 MJH Life Sciences
AJMC®
All rights reserved.